Skip to main content
. 2023 May 16;45(5):2757–2768. doi: 10.1007/s11357-023-00818-1

Table 3.

Reported length of rapamycin usage among men and women at the time the survey was completed

Length of rapamycin usage Women Men
 < 1 month 23.3% (17) 11.9% (31)
1–6 months 26% (19) 30.4% (79)
6 months–1 year 16.4% (12) 19.2% (50)
1–3 years 23.5% (18) 24.7% (61)
 > 3 years 15.0% (7) 9.6% (39)